Brain mixed glioma

C3_GLIOMIX

oligodendroglioma: A well-differentiated (WHO grade II), diffusely infiltrating neuroglial tumor, typically located in the cerebral hemispheres. It is composed predominantly of cells which morphologically resemble oligodendroglia. The neoplastic cells have rounded homogeneous nuclei and, on paraffin sections, a swollen, clear cytoplasm ('honeycomb' appearance). (Adapted from WHO)

Endpoint definition

↥

FinnGen phenotype data

321302 individuals

Apply sex-specific rule None

321302

Check conditions

HLP_C3_GLIOMIX

Filter registries

Cause of death: ICD-10 C71

Cause of death: ICD-9 191

Cause of death: ICD-8 191

Cancer registry: Topography ICD-O-3 C71

Cancer registry: Morphology ICD-O-3 9382

Cancer registry: Behaviour codes 3

Check pre-conditions, main-only, mode, ICD version

Look only at ICD versions C.O.D: 10, 8, 9

Check minimum number of events None

Include endpoints None

C3_GLIOMIX

Extra metadata

Level in the ICD hierarchy C

First used in FinnGen datafreeze DF4

Similar endpoints

↥

List of similar endpoints to Brain mixed glioma based on the number of shared cases.

Broader endpoints:

Narrower endpoints:

None

Show all endpoint correlations

Summary Statistics

↥

Key figures

	All	Female	Male
Number of individuals	25	11	14
Unadjusted prevalence (%)	0.01	0.01	0.01
Mean age at first event (years)	44.05	39.43	47.68

Mortality

Follow-up	Absolute risk	HR [95% CI]	p	N
1998–2019	-	-	-	-
15 years	-	-	-	-
5 years	-	-	-	-
1 year	-	-	-	-

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

↥

Index endpoint: C3_GLIOMIX – Brain mixed glioma
GWS hits:

Survival analyses between endpoints

↥

Plot

before Brain mixed glioma
after Brain mixed glioma

Loading survival analyses plot

Table

Loading survival analyses table

Drugs most likely to be purchased after Brain mixed glioma

↥